diphenylamine has been researched along with Cancer of Prostate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Deng, Y; Du, W; Li, X; Xu, R; Yan, G; Yu, J; Zhou, P | 1 |
| Ahn, MY; Choi, WS; De, U; Kim, HS; Kim, ND; Kim, TH; Lee, BM; Lee, YJ; Moon, HR; Patra, N; Yoon, JH | 1 |
| Bekiranov, S; Conaway, M; Gioeli, D; Petricoin, EF; Sebolt-Leopold, J; Weber, MJ; Wulfkuhle, JD; Wunderlich, W | 1 |
| Fiala, E; Katayama, S; Reddy, BS; Rivenson, A; Silverman, J; Weisburger, JH; Williams, GM | 1 |
4 other study(ies) available for diphenylamine and Cancer of Prostate
| Article | Year |
|---|---|
Metabolically stable diphenylamine derivatives suppress androgen receptor and BET protein in prostate cancer.
Topics: Androgen Receptor Antagonists; Animals; Cell Line, Tumor; Diphenylamine; HEK293 Cells; HT29 Cells; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Models, Chemical; Molecular Structure; PC-3 Cells; Prostatic Neoplasms; Proteins; Receptors, Androgen; Xenograft Model Antitumor Assays | 2020 |
A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Diphenylamine; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Inhibitory Concentration 50; Male; Prostatic Neoplasms; Receptors, Androgen; Up-Regulation; Vorinostat | 2013 |
Compensatory pathways induced by MEK inhibition are effective drug targets for combination therapy against castration-resistant prostate cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Line, Tumor; Cell Proliferation; Diphenylamine; Drug Synergism; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Orchiectomy; Prostatic Neoplasms; Protein Kinase Inhibitors; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays | 2011 |
Prostate adenocarcinoma in rats: induction by 3,2'-dimethyl-4-aminobiphenyl.
Topics: Adenocarcinoma; Aminobiphenyl Compounds; Aniline Compounds; Animals; Carcinoma in Situ; Diphenylamine; Male; Prostatic Neoplasms; Rats; Rats, Inbred F344 | 1982 |